| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 12/12/2001 | EP0814830A4 Lymphoblastoid natural interferon alpha production |
| 12/12/2001 | EP0809656B1 MONOCLONAL ANTIBODY SPECIFIC FOR beta-A4 PEPTIDE |
| 12/12/2001 | EP0522159B1 Antibody to pituitary adenylate cyclase activating peptide-pacap, hybridoma and assay for pacap |
| 12/12/2001 | EP0522091B1 Use of a mbp peptide for the preparation of a medicament for the treatment of multiple sclerosis |
| 12/12/2001 | CN1326510A Methods for producing denetically modified plants, plant materials and plant products produced thereby |
| 12/12/2001 | CN1326509A MOraxella catarrhalis ABSB034 polypeptides and uses thereof |
| 12/12/2001 | CN1326507A Promoters for gene expression in roots of plants |
| 12/12/2001 | CN1326506A Use of specific hybrid promoters for controlling tissue expression |
| 12/12/2001 | CN1326505A Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
| 12/12/2001 | CN1326467A Expression and export of angiostation and endostatin as immunofusins |
| 12/12/2001 | CN1326360A Use of enterobacterium protein OMPA for specific targeting towards antigen-presening cells |
| 12/12/2001 | CN1326354A Immortalized human kerationocyte cell line |
| 12/11/2001 | US6329573 Plants containing the gdhA gene and methods of use thereof |
| 12/11/2001 | US6329572 Plant promoter activated by fungal infection |
| 12/11/2001 | US6329571 Transforming immature embryo cells of indica rice by agrobacterium tumefaciens and selecting transformed cells by using a drug for selection |
| 12/11/2001 | US6329568 Tospovirus resistance in plants |
| 12/11/2001 | US6329566 Methods for the detection, treatment, and prevention of neurodegeneration |
| 12/11/2001 | US6329518 Nucleic acid from crepis plant coding for enzyme that catalyzes epoxygenation of carbon double bond at delta-12 position of fatty acid; efficient production of coatings, glues, plastics, surfactants and lubricants |
| 12/11/2001 | US6329503 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 12/11/2001 | US6329341 Method of treating septic shock |
| 12/11/2001 | US6329340 Human Defensin DEF-X |
| 12/11/2001 | US6329202 Antibodies directed against binding associated epitopes |
| 12/11/2001 | US6329201 An rna vector having alphavirus transcription sequences, a promoter and untranslated region from subgenomic venezuelan equine encephalitis, and alphavirus structural protein sequences; for directing expression of heterologous genes |
| 12/11/2001 | US6329199 A vector resistant to inactivation by human serum, produced in cells containing retroviral envelope protein sequence from feline endogenous virus, long terminal repeats sequences, signal and packaging sequences; for effective gene therapy |
| 12/11/2001 | US6329198 Production and use of human nm23 protein and antibodies therefor |
| 12/11/2001 | US6329197 DNA encoding galanin GALR3 receptors and uses thereof |
| 12/11/2001 | US6329195 A cell culture device having one chamber filled with a gas mixture that is sealed to a permeable membrane towards the culture medium chamber that is supplied with continuous liquid medium through inlet/outlet openings |
| 12/11/2001 | US6329190 Targetting adenovirus with use of constrained peptide motifs |
| 12/11/2001 | US6329181 A genetically engineered nucleic acid derived from parvovirus virions with a reduced number of replication competent particles; gene therapy |
| 12/11/2001 | US6329176 Culturing mammals cells containing a nucleic acid sequence that codes a saccharomyces endoprotease, in a serum free medium and isolating the protein from the medium |
| 12/11/2001 | US6329175 A nucleic acid molecule encoding a new cytokine; diagnosis and therapy for lymphoproliferative disorders including b-cell lymphoma and lymphatic leukemia |
| 12/11/2001 | US6329159 An antibody or antigen binding fragment which binds mammalian chemokine receptor and inhibits the binding of ligand to the receptor; therapy and diagnosis of inflammatory disease associated with mucosal tissues |
| 12/11/2001 | US6329137 Intact cell assay for protein tyrosine phosphatases using recombinant baculoviruses |
| 12/11/2001 | US6328973 Method of raising neutralizing antibodies against HIV |
| 12/11/2001 | US6328971 MAGE-1 derived nona peptides, and compositions thereof |
| 12/11/2001 | US6328970 Rapamycin position 27 conjugates |
| 12/11/2001 | US6328968 Organ transplant |
| 12/11/2001 | US6328963 For purifying or assaying human mp52 produced b genetic engineering techniques |
| 12/11/2001 | US6328960 Administering to transplant recipient mesenchymal stem cells in an amount effective to reduce an immune response of effector cells against an alloantigen to effector cells |
| 12/11/2001 | US6328958 Deleted adenovirus vectors and methods of making and administering the same |
| 12/11/2001 | US6328957 Heat shock proteins and the treatment of tumors |
| 12/11/2001 | US6328762 Prosthetic grafts |
| 12/11/2001 | CA2329482C Recombinant antibodies specific for tnf-.alpha. |
| 12/11/2001 | CA2221610C Method for reproducing conifers by somatic embryogenesis using a maltose enriched maintenance medium |
| 12/11/2001 | CA2162132C Hepatitis b virus mutants, reagents and methods for detection |
| 12/11/2001 | CA2136094C Methods and compositions for increasing the sensitivity of a cell to a dna damaging agent |
| 12/11/2001 | CA2117953C Human stromal derived factor 1 alpha and 1 beta and dnas encoding the same |
| 12/11/2001 | CA2066053C Recombinant retroviruses delivering vector constructs to target cells |
| 12/11/2001 | CA2065874C Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer |
| 12/11/2001 | CA2050477C T cell growth factor |
| 12/06/2001 | WO2001092877A2 Method of identifying and/or isolating stem cells |
| 12/06/2001 | WO2001092581A2 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 12/06/2001 | WO2001092578A2 Reagents and methods for identifying and modulating expression of genes regulated by retinoids |
| 12/06/2001 | WO2001092551A2 Duplexed parvovirus vectors |
| 12/06/2001 | WO2001092549A2 Method and composition for targeting an adenoviral vector |
| 12/06/2001 | WO2001092547A2 Modified bovine adenovirus having altered tropism |
| 12/06/2001 | WO2001092543A2 Improved methods of transfection |
| 12/06/2001 | WO2001092542A2 Integrin-targeting vectors having enhanced transfection activity |
| 12/06/2001 | WO2001092532A1 Cloning and sequencing of dac g5 allergen of dactylis glomerata pollen, preparation and use thereof |
| 12/06/2001 | WO2001092530A1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide |
| 12/06/2001 | WO2001092527A2 Regulators of apoptosis |
| 12/06/2001 | WO2001092526A1 Human kcnq5 potassium channel, methods and compositions thereof |
| 12/06/2001 | WO2001092520A1 Modified chemokine receptor ccr-3 and assay |
| 12/06/2001 | WO2001092513A1 METHODS FOR MEDIATING GENE SUPPRESION BY USING FACTORS THAT ENHANCE RNAi |
| 12/06/2001 | WO2001092508A1 Pseudo-type retrovirus vector containing membrane protein having hemagglutinin activity |
| 12/06/2001 | WO2001092502A1 Cutinase variants |
| 12/06/2001 | WO2001092500A1 Thermostable reverse transcriptases and uses thereof |
| 12/06/2001 | WO2001092496A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/06/2001 | WO2001092492A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 12/06/2001 | WO2001092491A2 Mammalian protein phosphatases identified by in-silico analysis |
| 12/06/2001 | WO2001092490A2 Isolated human aminotransferase proteins, nucleic acid molecules encoding human aminotransferase proteins, and uses thereof |
| 12/06/2001 | WO2001092485A1 DNAs ENCODING MAMMALIAN HISTAMINE RECEPTOR OF THE H4 SUBTYPE |
| 12/06/2001 | WO2001092484A2 Adjuvant preparation for the induction of specific immunity |
| 12/06/2001 | WO2001092483A1 An insulator element having enhancer-blocking properties |
| 12/06/2001 | WO2001092482A1 Method of concentrating and separating dopaminergic neurons |
| 12/06/2001 | WO2001092481A1 Method of preparing small hepatocytes preservable in freeze-dried state and method of preserving the same in freeze-dried state |
| 12/06/2001 | WO2001092480A1 Method of forming vertebrate pancreas in vitro |
| 12/06/2001 | WO2001092479A2 Method to determine the differentiation potential of a target cell |
| 12/06/2001 | WO2001092478A1 Method for production and cryopreservation of bovine embryos developed in vitro and frozen straw for direct transferring same |
| 12/06/2001 | WO2001092477A2 Three-dimensional skin model |
| 12/06/2001 | WO2001092475A2 Method for producing a recipient-specific tissue transplant or tissue implant |
| 12/06/2001 | WO2001092474A1 Alpha (2) macroglobulin receptors as a heat shock protein receptor and uses thereof |
| 12/06/2001 | WO2001092473A2 Method for cultivating a cartilage replacement and a biomatrix produced according to this method |
| 12/06/2001 | WO2001092472A1 Use of eicosanoids for tissue engineering |
| 12/06/2001 | WO2001092465A2 Maize glutamine synthetase gene promoter |
| 12/06/2001 | WO2001092337A2 Soluble ctla4 mutant molecules and uses thereof |
| 12/06/2001 | WO2001092322A1 Use of collagen of aquatic origin for producing support designed for tissue engineering, and resulting supports and biomaterials |
| 12/06/2001 | WO2001092321A2 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes |
| 12/06/2001 | WO2001092308A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 12/06/2001 | WO2001092307A2 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | WO2001092306A2 Therapeutic compounds for ovarian cancer |
| 12/06/2001 | WO2001092304A2 Transporters and ion channels |
| 12/06/2001 | WO2001092299A2 Adenovirus particles with mutagenized fiber proteins |
| 12/06/2001 | WO2001092294A2 Therapeutic anti-melanoma compounds |
| 12/06/2001 | WO2001091822A1 Shape memory thermoplastics and polymer networks for tissue engineering |
| 12/06/2001 | WO2001091821A1 Collagen-based supports for tissue engineering and preparation of biomaterials |
| 12/06/2001 | WO2001091820A1 Method for producing a bio-artificial transplant |
| 12/06/2001 | WO2001091819A1 Method for producing a recipient-specific tissue transplant |
| 12/06/2001 | WO2001091805A2 Compounds for targeting endothelial cells |
| 12/06/2001 | WO2001091801A2 Methods of transducing neural cells using lentivirus vectors |